Category: PSYCH STOCK NEWS

Small Pharma (DMT, DMTTF) $0.46 a Small and Extremely Interesting Psychedelic Company.

Conference Call Today at 12:00 EST. As the TSX chart above show, investors appear to be warming up the the idea. Not many investors...

Mindcure (MCURF) and Awakn Life Sciences (AWKNF) Seek to Distribute Ketamine Protocol for Alcohol Use Disorder.

MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across United States and Canada through iSTRYM, MINDCURE's Digital Therapeutics Platform

Psychedelic Drugs ‘Far Exceed’ Cannabis Investment Potential (CNBC)

Shark Tank’s Kevin O’Leary, Wesana (WSNAF) CEO Daniel Carcillo and director at Mass General Hospital’s Center for the Neuroscience of Psychedelics Dr. Sharmin Ghaznavi. Recent Wall Street...

Psychedelic Therapeutics Sector Outlook Released (Valhalla Ventures)

Valhalla Ventures backs visionary founders at the forefront of social and technological movements that younger generations care about most. The Psychedelic Renaissance is roaring. Over the past...

Ketamine Testimonials On Local Nashville and Miami News. Lamar Odom on Good Morning America.

News Channel 5 Nashville. Ketamine infusions are being used to treat patients with severe depression. The medicine is also a treatment for curb substance abuse addictions.

Pasithea Therapeutics (KTTA) Opens its First Ketamine Therapy Clinic in the United Kingdom

Pasithea Therapeutics recently raised $24 million at its initial public offering (“IPO”). The Company’s Common Stock began trading on The Nasdaq Capital Market on September 15, 2021, under the...

Ehave (EHVVF) To Conduct Ketamine Clinical Trial In Miami, Florida

"I believe that we are on the verge of curing, as opposed to simply treating, certain psychiatric maladies." Dr. Jeffrey Kamlet, Chief Medical Officer of Ehave.

KCSA Psychedelics Conference. Wednesday, October 13th.

The KCSA Psychedelics Conference features live presentations and speakers who will address the various investment opportunities in psychedelic treatments for mental health disorders.
Most Popular

Ehave, Inc. Announces its KetaDASH Mobile Unit Delivered to Miami Beach.

MIAMI, June 03, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced...

Australian Icannex (IHL:ASX) Headed to NASDAQ?

Incannex completes Phase 2 trial for its cannabinoid drug for sleep apnea, flags Nasdaq listing in 2022

Testimonial: The Ibogaine Clinic, Playa Del Carmen

VIDEO TESTIMONIALS https://youtu.be/hrrLoxuR2oo VISIT WEBSITE